Navis Wealth Advisors’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
Other funds holding BBH
MIM
CCA
BFG
Navis Wealth Advisors's BBH Position: Q2 2026 in Review
Navis Wealth Advisors held its VanEck Biotech ETF (BBH) position steady in Q2 2026 at 3,998 shares worth $813K. The position accounts for 0.31% of the portfolio, ranked #68.
Navis Wealth Advisors first reported a position in BBH in Q4 2020 and has held it in 23 quarters since. 110 funds tracked by Wall St. Rank hold BBH as of Q2 2026.
- Navis Wealth Advisors held 3,998 shares of VanEck Biotech ETF worth $813K as of Q2 2026.
- Navis Wealth Advisors left its VanEck Biotech ETF share count unchanged in Q2 2026.
- VanEck Biotech ETF made up 0.31% of Navis Wealth Advisors's portfolio in Q2 2026, its #68 holding.
- Navis Wealth Advisors first reported a position in VanEck Biotech ETF in Q4 2020 and has held it in 23 quarters since.
- 110 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2026.
Based on Navis Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.